戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                Of these, 10 were treated with corticosteroids, and three of these patient
2                                              Group 2 (n=30) were treated with the same schedule and had sparse dolutegrav
3 ive staining diminished when B16-F1 cell-inoculated animals were treated with trolox, nifedipine, or the adenosine recept
4 es of 38 patients, an equal number of eyes (19 in each arm) were treated with standard-fluence and reduced-fluence PDT.
5                                                    Biofilms were treated with ozonized saline solution at different conce
6 e challenge with RSV infection but was inhibited when BMDCs were treated with GSK J4 prior to sensitization.
7  Trichoplusia ni (soybean, green bean, cotton, and cabbage) were treated with the biopesticide AfMNPV baculovirus in a do
8                                         Positive candidates were treated with levofloxacin.
9 tive antibody [CDC PRA+], C1q+) heart transplant candidates were treated with the combination of belatacept and PI therap
10                   Mice fed omega3-rich or omega6-rich diets were treated with TCDD and injected subcutaneously with AHR-c
11                        Of the randomised patients, 107 each were treated with fingolimod and IFN beta-1a for up to 2 year
12        Six patients with recurrent PDGFRalpha-driven glioma were treated with dasatinib and everolimus.
13 eyes of 79 patients with circumscribed choroidal hemangioma were treated with PDT.
14  inflammation due to obesity enhances tumor formation, mice were treated with IgG or anti-F4/80 antibodies to deplete mac
15 as responsible for structure alterations in the lungs, mice were treated with N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-p
16                                           C57BL/6 male mice were treated with broad-spectrum antibiotics for 4 weeks to d
17 I-AM or after establishment of autoimmune myocarditis, mice were treated with the immunoproteasome inhibitor ONX 0914.
18                                       WT and Nod2(-/-) mice were treated with the carcinogen dimethylbenz[a]anthracene (D
19                              Methods: Female MMTV-PyMT mice were treated with pexidartinib, a colony-stimulating factor 1
20 sect the mechanisms of TSLP-mediated type 2 responses, mice were treated with TSLP and antigen to evaluate cellular immun
21                                                 Septic mice were treated with [(C2S, 3S, 4R)-1-O-(alpha-d-galactopyranosy
22                                           Transplanted mice were treated with vehicle or di-n-butyl-phthalate (DBP, a pla
23                    Here, Akita mice, type 1 diabetic model, were treated with the visual pigment chromophore, 9-cis-retin
24                            Cultured rat hippocampal neurons were treated with cerebrospinal fluid (CSF) from patients wit
25                             Infected mice remained naive or were treated with the reverse transcriptase (RT) inhibitor la
26                                                    Patients were treated with intravitreal injections with bevacizumab; r
27                                                    Patients were treated with steroid monotherapy (28.9% of cases), NSAID
28                                                    Patients were treated with up to eight courses of the hyper-CVAD regim
29                                                    Patients were treated with vitamin K antagonists (48.4%), parenteral h
30                           A total of 3,043 (36.2%) patients were treated with OAC at some time during the study period.
31                                                All patients were treated with anti-IL-6R antibody and/or IVIG, which led
32                                                All patients were treated with biguanides and/or diamidines or azoles with
33                                                All patients were treated with curative-intent chemoradiotherapy (CRT).
34                                                All patients were treated with definitive chemoradiation (median dose 50.4
35                                                All patients were treated with gemcitabine and S-1 (GS)-based chemotherapi
36                                        Twenty-nine patients were treated with infliximab.
37                                                The patients were treated with 4 mg baricitinib twice daily for 2 days, fo
38                                 Subjects with periodontitis were treated with scaling and root planing (SRP).
39                                                     Rabbits were treated with the beta3 AR agonists CL316,243 or ASP9531,
40 diabetic, hypertensive heart failure rat (mRen27/tetO-shIR) were treated with empagliflozin (10 mg/kg/d) or vehicle for 4
41                                     Most patients with SMPE were treated with embolectomy (98.9% [91 of 92]), while ECMO
42                                                   Spheroids were treated with 5-Fluorouracil for five days through contin
43               Following the initial growth phase, spheroids were treated with auristatin as small molecule (MMAE) or as a
44 ty-two patients from 7 medical centers in the United States were treated with axi-cel and were included in a modified int
45          CD-1 mice infected with the T. cruzi Brazil strain were treated with RvD1.
46                  Twenty-seven patients with low CrAg titers were treated with antifungal therapy and 22 (81%) responded w
47 abetes with angiographic evidence of 2- or 3-vessel CAD who were treated with either PCI or isolated CABG from 2008 to 20
48 ients with histologically confirmed stage IIIB-IV NSCLC who were treated with immune checkpoint blockade between June 201
49        Patients presenting with cavitary retinoblastoma who were treated with IAC.
50 ing CA20948 somatostatin receptor-positive tumor xenografts were treated with (177)Lu-DOTATATE or sham-treated and coinje